Clinical Trial Update: Belgian Antithrombin Deficiency Registry

View source ↗

Summary

A Belgian registry study to collect data on Antithrombin III deficiency, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antithrombin Iii Deficiency

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Antithrombin III Deficiency | Status: NOT_YET_RECRUITING